LIPAC Oncology

    OverviewSuggest Edit

    LIPAC Oncology is a clinical-stage company offering a drug delivery platform for developing therapies that target cancer in challenging parts of the body. Its proprietary technology, LiPax, is a locally delivered formulation of paclitaxel that is being developed for the intravesical treatment of non-muscle invasive bladder cancer and other intracavitary cancer indications.
    HQPomona, CA, US

    Latest Updates

    Employees (est.) (May 2020)3
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    Key People/Management at LIPAC Oncology

    Michael Oefelein

    Michael Oefelein

    Co-Founder & Chief Medical Officer
    Will A. Robberts

    Will A. Robberts

    Co-Founder, President & Chief Financial Officer
    Ramachandran Thirucote

    Ramachandran Thirucote

    Co-Founder, Chairman & Chief Technology Officer
    Josh Hammermesh

    Josh Hammermesh

    Independent Board Member
    Show more

    LIPAC Oncology Office Locations

    LIPAC Oncology has an office in Pomona
    Pomona, CA, US (HQ)
    3670 W Temple Ave #270
    Show all (1)

    LIPAC Oncology Financials and Metrics

    Summary Metrics

    Founding Date


    LIPAC Oncology Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    LIPAC Oncology Online and Social Media Presence

    Embed Graph

    LIPAC Oncology News and Updates

    LIPAC Oncology Announces Two-Year Recurrence Free Survival Data for Phase 1/2a Study of LiPax in Patients With Non-Muscle Invasive Bladder Cancer

    MENLO PARK, Calif., June 9, 2021 /PRNewswire/ -- LIPAC Oncology LLC., a pharmaceutical company utilizing its next generation precision liposomal technology to locally deliver taxanes to target tissues, today announced the positive results from the two-year follow-up for TD-001, its Phase...

    LIPAC Oncology Frequently Asked Questions

    • When was LIPAC Oncology founded?

      LIPAC Oncology was founded in 2017.

    • Who are LIPAC Oncology key executives?

      LIPAC Oncology's key executives are Michael Oefelein, Will A. Robberts and Ramachandran Thirucote.

    • How many employees does LIPAC Oncology have?

      LIPAC Oncology has 3 employees.

    • Who are LIPAC Oncology competitors?

      Competitors of LIPAC Oncology include Janux Therapeutics, Therapyx and 7 Hills Pharma.

    • Where is LIPAC Oncology headquarters?

      LIPAC Oncology headquarters is located at 3670 W Temple Ave #270, Pomona.

    • Where are LIPAC Oncology offices?

      LIPAC Oncology has an office in Pomona.

    • How many offices does LIPAC Oncology have?

      LIPAC Oncology has 1 office.